PanGen Biotech Inc. (KOSDAQ:222110)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,360.00
+50.00 (0.94%)
At close: Jan 23, 2026
12.96%
Market Cap75.30B
Revenue (ttm)15.27B +11.3%
Net Income1.64B
EPS126.75
Shares Out13.49M
PE Ratio44.02
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,521
Average Volume17,568
Open5,310.00
Previous Close5,310.00
Day's Range5,100.00 - 5,380.00
52-Week Range4,305.00 - 7,400.00
Beta-0.14
RSI45.82
Earnings Daten/a

About PanGen Biotech

PanGen Biotech Inc. operates as a biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production. In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as technology transfer service. PanGen Biotech Inc. was founded in 1999 and is based in Suwon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 222110
Full Company Profile

Financial Performance

Financial Statements